NCT01512914

Brief Summary

Studies evaluating intraperitoneal local anesthetic instillation for pain relief after laparoscopic procedures have provided conflicting results. This randomized, double-blind study was designed to assess the effects of a novel intraperitoneal local anesthetic administration technique using nebulization on pain relief after gynecologic laparoscopic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started May 2008

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

January 15, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 19, 2012

Completed
Last Updated

January 19, 2012

Status Verified

January 1, 2012

Enrollment Period

1.3 years

First QC Date

January 15, 2012

Last Update Submit

January 18, 2012

Conditions

Keywords

Gynecologic laparoscopic surgeryPostoperative painNebulizationRopivacaine

Outcome Measures

Primary Outcomes (1)

  • postoperative pain

    Postoperative pain was assessed by NRS (0 to 10 points) at rest (static NRS) and after a deep inspiration or cough (dynamic NRS). The proportion of patients with adequate pain control after surgery (dynamic NRS \< 3) will also be assessed.

    24 hours

Secondary Outcomes (4)

  • morphine consumption

    24 hours

  • Unassisted walking time

    24 hours

  • Hospital stay

    between surgery and discharge

  • hospital morbidity

    up to discharge

Study Arms (4)

CONTROL group

PLACEBO COMPARATOR
Drug: saline

PREOPERATIVE nebulization

EXPERIMENTAL
Drug: Ropivacaine 30 mg

POSTOPERATIVE nebulization

EXPERIMENTAL
Drug: Ropivacaine 30 mg

INSTILLATION group

ACTIVE COMPARATOR
Drug: Ropivacaine 100 mg

Interventions

preoperative instillation of saline 20 ml, nebulization of ropivacaine 1% 3 ml (30 mg) before surgery and nebulization of saline 3 ml after surgery

PREOPERATIVE nebulization

preoperative instillation of ropivacaine 0,5% 20 ml (100 mg) and nebulization of saline 3 ml before and after surgery

INSTILLATION group
salineDRUG

preoperative instillation of saline 20 ml and nebulization of saline before and after surgery

CONTROL group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Females 18-70 years old, ASA score 1 - 3;
  • scheduled for laparoscopic operative surgery in the Obstetrics and Gynecology unit;
  • free from pain in preoperative period, without habitual analgesic use;
  • without cognitive impairment or mental retardation, who gave a written informed consent

You may not qualify if:

  • Females under 18 or over 70;
  • ASA 4 or 5;
  • emergency/urgency criteria, postoperative admission in a intensive care unit with sedation or ventilatory assistance; cognitive impairment or mental retardation;
  • habitual analgesic use; progressive degenerative diseases of the CNS;
  • convulsions or chronic therapy with antiepileptic drugs;
  • severe hepatic or renal impairment;
  • pregnancy or lactation;
  • allergy to one of the specific substances used in the study;
  • acute infectious disease or inflammatory chronic disease, alcohol or drug addiction;
  • any kind of communication problem;
  • neurologic or psychiatric disease;
  • no written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Gerardo Hospital

Monza, MB, 20052, Italy

Location

Related Publications (3)

  • Goldstein A, Grimault P, Henique A, Keller M, Fortin A, Darai E. Preventing postoperative pain by local anesthetic instillation after laparoscopic gynecologic surgery: a placebo-controlled comparison of bupivacaine and ropivacaine. Anesth Analg. 2000 Aug;91(2):403-7. doi: 10.1097/00000539-200008000-00032.

  • Alkhamesi NA, Peck DH, Lomax D, Darzi AW. Intraperitoneal aerosolization of bupivacaine reduces postoperative pain in laparoscopic surgery: a randomized prospective controlled double-blinded clinical trial. Surg Endosc. 2007 Apr;21(4):602-6. doi: 10.1007/s00464-006-9087-6. Epub 2006 Dec 16.

  • Greib N, Schlotterbeck H, Dow WA, Joshi GP, Geny B, Diemunsch PA. An evaluation of gas humidifying devices as a means of intraperitoneal local anesthetic administration for laparoscopic surgery. Anesth Analg. 2008 Aug;107(2):549-51. doi: 10.1213/ane.0b013e318176fa1c.

MeSH Terms

Conditions

Pain, Postoperative

Interventions

RopivacaineSodium Chloride

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Pablo M Ingelmo, MD

    San Gerardo Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 15, 2012

First Posted

January 19, 2012

Study Start

May 1, 2008

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

January 19, 2012

Record last verified: 2012-01

Locations